Up Front MattersEditorial
You have accessRestricted Access
Molecular Characterization of Membranous Nephropathy: Quo Vadis?
Fernando C. Fervenza and Richard J. Glassock
JASN June 2022, 33 (6) 1057-1059; DOI: https://doi.org/10.1681/ASN.2022040395
Fernando C. Fervenza
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota
2Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California
Richard J. Glassock
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota
2Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California


You do not have access to the full text of this article, the first page of the PDF of this article appears above.
In this issue
Molecular Characterization of Membranous Nephropathy: Quo Vadis?
Fernando C. Fervenza, Richard J. Glassock
JASN Jun 2022, 33 (6) 1057-1059; DOI: 10.1681/ASN.2022040395
Jump to section
More in this TOC Section
Up Front Matters
Cited By...
- No citing articles found.